ExploreWatchlistsPricing
  1. JP-listed companies
  2. EIKEN CHEMICAL CO.,LTD.
  3. Financials
  4. Revenue

EIKEN CHEMICAL CO.,LTD. (4549)

Market cap
¥108B
P/E ratio
44.6x
Manufactures and sells diagnostic reagents for the medical field through operations in Japan and China, with plans to expand into the American market.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
Mar 31, 202641,899+3.35%
Mar 31, 202540,539+1.22%
Mar 31, 202440,052-7.44%
Mar 31, 202343,271+0.64%
Mar 31, 202242,996+11.20%
Mar 31, 202138,667+5.69%
Mar 31, 202036,585+2.30%
Mar 31, 201935,761+2.20%
Mar 31, 201834,991+5.16%
Mar 31, 201733,274+3.45%
Mar 31, 201632,163+3.70%
Mar 31, 201531,014+3.29%
Mar 31, 201430,027+4.82%
Mar 31, 201328,645+3.40%
Mar 31, 201227,702

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat